| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 08/03/2006 | WO2006081072A1 Antagonists of the mglu receptor and uses thereof |
| 08/03/2006 | WO2006080745A1 New 4,5,6,7-tetrahydro-[1,2]dithiolo[4,3-c]pyridine-3-thione compounds |
| 08/03/2006 | WO2006080647A1 Photochromic monomers, photochromic polymers based on the same, photochromic recording media comprising the photochromic polymers, and 3d read/write optical memory comprising the recording media |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006080439A1 Tricyclic compound |
| 08/03/2006 | WO2006080406A1 Tricyclic compounds |
| 08/03/2006 | WO2006079916A1 Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation |
| 08/03/2006 | WO2006079789A1 Pyrimidothiophene compounds having hsp90 inhibitory activity |
| 08/03/2006 | WO2006079644A1 Indolopyridines, benzofuranopyridines and benzothienopyridines |
| 08/03/2006 | WO2006079637A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/03/2006 | WO2006064355A3 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 08/03/2006 | WO2006055268A3 Pyrimidothienoindazoles capable of inhibiting tyrosine kinases of the epidermal growth factor |
| 08/03/2006 | US20060173068 Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 08/03/2006 | US20060173041 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 08/03/2006 | US20060172995 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 08/03/2006 | CA2596527A1 Igf-1r inhibitors |
| 08/03/2006 | CA2595882A1 Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation |
| 08/03/2006 | CA2595247A1 Indolopyridines, benzofuranopyridines and benzothienopyridines |
| 08/03/2006 | CA2595170A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/02/2006 | EP1686119A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/02/2006 | EP1685136A1 Use of thienopyrimidines |
| 08/02/2006 | EP1685117A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide |
| 08/02/2006 | EP1685100A1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 08/02/2006 | EP1684762A2 Urea derivatives as kinase modulators |
| 08/02/2006 | EP1430050B1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 08/02/2006 | EP1412362B1 THIENO¬2,3-d|PYRIMIDINEDIONES AS INHIBITORS OF T-CELLS PROLIFERATION |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/02/2006 | CN1812994A Process for preparing amorphous form of a medicament - blood platelet coagulation inhibitor |
| 08/02/2006 | CN1812993A Process for preparing crystalline polymorph of blood platelet coagulation inhibitor |
| 08/02/2006 | CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084162 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084152 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
| 07/27/2006 | WO2006077888A1 Novel condensed polycyclic aromatic compound and use thereof |
| 07/27/2006 | WO2006077412A1 Thienopyrroles useful in the treatment of inflammation |
| 07/27/2006 | WO2006050128A3 Heterocyclical chromophore architectures |
| 07/27/2006 | WO2006014647A3 Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof |
| 07/27/2006 | WO2004033397A3 Activity-based probes, and methods of their preparation and use |
| 07/27/2006 | US20060166971 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 07/27/2006 | US20060166829 N-Heterocycl phenyl-substituted cyclic ketoenols |
| 07/27/2006 | CA2595127A1 Mitotic kinesin inhibitors |
| 07/27/2006 | CA2594665A1 Thienopyrroles useful in the treatment of inflammation |
| 07/26/2006 | EP1683799A1 3-Amino-6-aryl(or 6-heteroaryl)-4-R²-thieno[2,3-b]pyridin-2-carboxylic acid amides, pharmaceutical compositions comprising the said and their use as inhibitors of TNFalpha release |
| 07/26/2006 | EP1683794A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 07/26/2006 | EP1682553A1 Thienopyrazoles |
| 07/26/2006 | EP1682519A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 07/26/2006 | EP1682516A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/26/2006 | EP1682502A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| 07/26/2006 | CN1809575A Thienopyridone derivatives as kinase inhibitors |
| 07/26/2006 | CN1809560A Thiazolylpiperidine derivatives as mtp inhibitors |
| 07/26/2006 | CN1809347A Selective spirocyclic glucocorticoid receptor modulators |
| 07/26/2006 | CN1807428A Condensed ring unit terminated oligomerized thiophen analog high mobility organic semi-conducting material and its uses |
| 07/26/2006 | CN1266142C Polysubstituted benzo hetero aromatic ring and method for one step synthesizing polysubstituted benzo hetero aromatic ring |
| 07/25/2006 | US7081456 N-substitued-4-(3-oxo(thio)chromeno[4,3-c]pyrazol-2(3H)-yl) benzamides or N-substituted-4-(3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl) benzamides; CD80 antigen antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 07/25/2006 | US7081455 sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 07/20/2006 | WO2006075023A2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/20/2006 | WO2006074919A2 3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS |
| 07/20/2006 | US20060160887 Medicinal composition |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160878 For therapy of central nervous system disorders related to or affected by the 5-HT6 receptor |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160829 Thienopyrimidine compounds and use thereof |
| 07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
| 07/19/2006 | EP1681292A1 3-Amino-6-aryl(or 6-heteroaryl)-thieno¬2,3-b|pyridin-2-carboxylic acid amides, pharmaceutical compositions comprising the said and their use as inhibitors of TNFalpha release |
| 07/19/2006 | EP1680481A1 New compound capable of being used in organic layer of organic light emitting device |
| 07/19/2006 | EP1680430A2 Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate |
| 07/19/2006 | EP1680429A1 Thieno-pyridinone derivatives as kinase inhibitors |
| 07/19/2006 | EP1680420A2 Compounds, compositions, and methods |
| 07/19/2006 | EP1372640B1 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders |
| 07/19/2006 | EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor |
| 07/19/2006 | EP1226193B1 Process for the preparation of ethylene polymers |
| 07/19/2006 | CN1803792A Phenanthrene/thiophene hybridized high-mobility organic semiconductor and application thereof |
| 07/19/2006 | CN1264846C Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 07/18/2006 | US7078013 Pretargeting methods and compounds |
| 07/13/2006 | WO2006074230A2 Method of making dorzolamide hydrochloride |
| 07/13/2006 | WO2006074066A1 Non-crystalline formulation comprising clopidogrel |
| 07/13/2006 | WO2006073886A1 Olanzapine pamoate dihydrate |
| 07/13/2006 | WO2006013095A3 Condensed pyridines as kinase inhibitors |
| 07/13/2006 | WO2006004833A3 Pyrrolotriazine kinase inhibitors |
| 07/13/2006 | WO2005102330A3 Amino methylated 2-pyridinones |
| 07/13/2006 | WO2004078908A3 Alpha-keto carbonyl calpain inhibitors |
| 07/13/2006 | US20060155132 Method of making dorzolamide hydrochloride |
| 07/13/2006 | US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora) |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | DE102004063223A1 New quinoline derivatives are ephrin receptor kinase inhibitors useful for the treatment of e.g. blood vessels diseases, hyperproliferations, chronic or acute neurodegenerative diseases, psoriasis, eczema and scleroderma |
| 07/12/2006 | EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative |
| 07/12/2006 | EP1678184A1 3-(4-aminophenyl)thienopyrimid-4-one derivatives as mch r1 antagonists for the treatment of obesity, diabetes, depression and anxiety |
| 07/12/2006 | EP1678166A2 Protein kinase inhibitors |
| 07/12/2006 | EP1678121A2 Tao kinase modulators and methods of use |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1394156B1 Chromene compound |
| 07/12/2006 | CN1802366A C-glycoside derivatives and salts thereof |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074928 Polymorphs of clopidogrel hydrogensulfate |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | CA2227984C Aza-anthracyclinone derivatives |